← Back to Patent Explorer
US3621026A Expired / Lapsed US ⏱️ 0.0 years remaining

Blood-sugar-lowering sulfonylamino pyrimidines

Assignee: Bayer Pharma AG
•
Filing: 1968-12-19
•
Granted: 1971-11-16
•
Expires: 1988-12-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Sulfonylamino pyrimidine derivatives of the formula WHEREIN R is lower alkyl, lower alkoxy, lower-alkoxy-loweralkoxy, cycloalkyl or cycloalkoxy having five or six carbon atoms, or phenyl; R1 is hydrogen or lower alkyl; R2, R3, and R4 are members of the group consisting of hydrogen, lower alkyl, lower alkoxy, lower alkanoyl, lower alkanoyl-amino, trifluoromethyl, halogen, aminocarbonyl, benzyloxy, lower alkenyloxy, and phenyl; N IS 1 OR 2; AND X is a carbon-to-carbon bond or CH2, and the salts of the derivatives with physiologically tolerated bases lower the blood sugar level in warm-blooded animals.

Inventors

  • 👤 Klaus Gutsche
  • 👤 Eberhard Schroder

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 20:26
CPC Classifications
C; C07; C07D; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/69; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isopropylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-chloroanilide.
Claim 2
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5isobutylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-chloroanilide.
Claim 3
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-methylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-chloroanilide.
Claim 4
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isopropoxypyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-chloroanilide.
Claim 5
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isobutylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-ethoxy-5-chloroanilide.
Claim 6
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isobutylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-chloro-N-methylanilide.
Claim 7
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isopropoxypyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-ethoxy-5-methylanilide.
Claim 8
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isobutylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-chloroanilide.
Claim 9
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isobutylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-fluoroanilide.
Claim 10
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isobutylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-ethoxy-5-methylanilide.
Claim 11
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-isopropoxypyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-methylanilide.
Claim 12
Dependent Claim 15 words
A compound as set forth in claim 1, wherein said derivative is 4-(5-ethylpyrimidin-2-yl)-sulfonamido-phenylacetic acid 2-methoxy-5-chloroanilide.

References Cited (Backward Citations)

US3377351A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1974-11-15 1975-05-17 1975-11-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1978-11-15 1979-05-17 1979-11-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1982-11-15 1983-05-17 1983-11-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag